ERYTHROMYCIN ETHYLSUCCINATE CRYSTALLINE HYDRATE, PREPARATION AND USES THEREOF

Title:

ERYTHROMYCIN ETHYLSUCCINATE CRYSTALLINE HYDRATE, PREPARATION AND USES THEREOF

Document Type and Number:

WIPO Patent Application WO/2012/142960

Kind Code:

A1

Abstract:

Disclosed is an anti-infective drug―macrolide compound, preparation and uses thereof. Macrolide compound, namely erythromycin ethylsuccinate crystalline hydrate, which has less moisture absorption and good storage stability, can be used in the preparation of drugs for the treatment and prevention of human or animal infectious diseases caused by Gram-positive or negative bacteria.

More Like This:

WO/2001/092281	METHOD USED FOR TRANSFORMING THE CARBONYL FUNCTION IN POSITION 4'' OF A CLADINOSE UNIT OF AN AZA MACROLIDE INTO AN AMINE DERIVATIVE
WO/1999/000125	9A-AZA-3-KETOLIDES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT

Inventors:

LIU LI (CN)

Application Number:

PCT/CN2012/074423

Publication Date:

October 26, 2012

Filing Date:

April 20, 2012

Export Citation:

Click for automatic bibliography generation Help

Assignee:

LIU LI (CN)

International Classes:

C07H17/08; A61K31/7048; A61P31/04

Foreign References:

CN1098106A	1995-02-01
US5118799A	1992-06-02
CN1602887A	2005-04-06

Other References:

ZHANG, T. ET AL.: "Development of Taste Masking Methods in Oral Pharmaceuticals", HEBEI CHEMICAL ENGINEERING AND INDUSTRY, vol. 30, no. 11, November 2007 (2007-11-01), pages 20 - 22,25

Attorney, Agent or Firm:

BEIJING DEQUAN LAW & PATENT FIRM (CN)
北京市德权律师事务所 (CN)

Download PDF:

View/Download PDF PDF Help

Claims:

Previous Patent: HIGH PURITY OF CASPOFUNGIN OR SALTS THEREOF, AND PREPARATION METHOD THEREFOR, AND USE THEREOF

Next Patent: GLYCOPROTEIN COMPOSITION WITH LOW RESIDUAL SOLVENT LEVEL, AND PREPARATION METHOD AND USE THEREOF